scholarly article | Q13442814 |
P50 | author | Stefan Mrdenovic | Q57016572 |
P2093 | author name string | Michael R Freeman | |
Leland W K Chung | |||
Haiyen E Zhau | |||
Sungyong You | |||
Michael S Lewis | |||
Yi-Tsung Lu | |||
Jayoung Kim | |||
Jen-Ming Huang | |||
Ruoxiang Wang | |||
Lijuan Yin | |||
Quanlin Li | |||
Isla Garraway | |||
Qinlong Li | |||
Lawrence W Jones | |||
Gina C-Y Chu | |||
Jason B-Y Wu | |||
P2860 | cites work | FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer | Q24307471 |
Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells | Q24641991 | ||
Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18 | Q28202540 | ||
Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer | Q28478514 | ||
Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development | Q28506942 | ||
Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study | Q30417094 | ||
Collective invasion in breast cancer requires a conserved basal epithelial program | Q30573307 | ||
Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. | Q31146575 | ||
Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells | Q33645250 | ||
Identification of methylated genes associated with aggressive bladder cancer | Q33680247 | ||
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. | Q34192343 | ||
Keratin 8/18 regulation of cell stiffness-extracellular matrix interplay through modulation of Rho-mediated actin cytoskeleton dynamics | Q34299746 | ||
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer | Q34340156 | ||
Serpins promote cancer cell survival and vascular co-option in brain metastasis | Q34407528 | ||
Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S | Q34599128 | ||
Loss of the keratin cytoskeleton is not sufficient to induce epithelial mesenchymal transition in a novel KRAS driven sporadic lung cancer mouse model | Q34639081 | ||
Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine? | Q35141115 | ||
EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis | Q35190722 | ||
Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier | Q35407588 | ||
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study | Q35683537 | ||
Krüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression | Q35861040 | ||
Differentiation potential of urothelium from patients with benign bladder dysfunction | Q35966453 | ||
Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis | Q36494588 | ||
Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients | Q36530753 | ||
Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters | Q36607592 | ||
Structural and regulatory functions of keratins. | Q36791981 | ||
Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer. | Q37301697 | ||
RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization | Q37648868 | ||
Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer | Q37683681 | ||
Matrix metalloproteinases: potential therapy to prevent the development of second malignancies after breast radiotherapy | Q38022954 | ||
Generation of clinically relevant "induced pluripotent stem" (iPS) cells. | Q38069587 | ||
Reprogramming cancer cells in endocrine-related tumors: open issues. | Q38168603 | ||
Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review | Q38209356 | ||
The network of epithelial-mesenchymal transition: potential new targets for tumor resistance | Q38255668 | ||
The reciprocal interactions between astrocytes and prostate cancer cells represent an early event associated with brain metastasis | Q39027973 | ||
Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage | Q39534958 | ||
Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis | Q40244672 | ||
A new human prostate carcinoma cell line, 22Rv1. | Q40933318 | ||
Suprabasal change and subsequent formation of disulfide-stabilized homo- and hetero-dimers of keratins during esophageal epithelial differentiation. | Q42483380 | ||
Early expression of type I K13 keratin in the progression of mouse skin papillomas. | Q44869872 | ||
Phosphatidylinositol 3-kinase regulates early differentiation in human laryngeal keratinocytes | Q46608353 | ||
Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA). | Q47887528 | ||
Reduced expression of cytokeratin 4 and 13 is a valuable marker for histologic grading of esophageal squamous intraepithelial neoplasia | Q47906877 | ||
Distribution of metastatic sites in patients with prostate cancer: A population-based analysis | Q48929994 | ||
Semaphorin signaling in bone. | Q50936117 | ||
Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix | Q71649289 | ||
Keratin mRNA for detecting micrometastasis in cervical lymph nodes of oral cancer | Q73247282 | ||
Gene expression of differentiation-specific keratins in oral epithelial dysplasia and squamous cell carcinoma | Q73711657 | ||
Loss of cytokeratin 13 expression in squamous cell carcinoma of the tongue is a possible sign for local recurrence | Q80856745 | ||
A proteomics analysis of cell signaling alterations in colorectal cancer | Q81234559 | ||
A de novo missense mutation in the keratin 13 gene in oral white sponge naevus | Q81616289 | ||
P433 | issue | 51 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 84645-84657 | |
P577 | publication date | 2016-12-01 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells | |
P478 | volume | 7 |
Q41711884 | A 25-gene classifier predicts overall survival in resectable pancreatic cancer |
Q64064768 | Evidence for an oncogenic role of HOXC6 in human non-small cell lung cancer |
Q61797777 | High Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients |
Q42776923 | Isolation and functional interrogation of adult human prostate epithelial stem cells at single cell resolution. |
Q54216107 | KF-finder: identification of key factors from host-microbial networks in cervical cancer. |
Q47104201 | KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma |
Q64941550 | Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics. |
Q55289611 | Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity. |